Reframing vitiligo in clinical and managed care settings

Vitiligo is a chronic autoimmune disease characterized by the destruction of melanocytes, the cells responsible for producing skin pigment. While the condition is not painful or contagious, its visible nature can make it highly stigmatizing for patients, contributing to a broader psychosocial burden that extends beyond physical symptoms alone. In clinical and managed care settings, vitiligo is often viewed primarily through its physical presentation; however, this perspective can overlook the long-term and non-physical impacts of the disease. Because vitiligo is a chronic condition, it requires ongoing consideration within care planning and benefit design, particularly as patients may need sustained support over time. Recognizing both the clinical characteristics and the lived experience of patients is essential to ensuring more comprehensive, patient-centered approaches within managed care frameworks.